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This report is a collaborative initiative between the National Clinical Programme for 
Paediatrics and Neonatology (NCPPN) and the National Perinatal Epidemiology 
Centre (NPEC). The Therapeutic Hypothermia (TH) steering committee has overseen 
the governance for this project. A Multi-Disciplinary Team (MDT) approach has been 
adopted in order to best inform this process. 
This report is based on the 19 maternity sites in Ireland. We would like to acknowledge 
with much appreciation each hospitals role in supporting the data collection process 
for this report. From the onset it was encouraging to observe the commitment from 
each hospital site towards the project. Their assistance and enthusiasm during the data 
collection phase and overall is greatly appreciated. Without their participation this report 
would not have come to fruition.
This report serves as a platform to continue the national review process in order to attain 
valuable data which can influence clinical practice in a constructive way.
We would like to thank the Clinical Strategy and Programme Division of the HSE and 
the National Women and Infants Health Programme (NWIHP) for their commitment to 
this project and the funding they contributed in order to progress this important piece 
of work. It is envisaged through the formation of a national electronic-register there 
will be a recording of all data around these cases. This data can then be analysed from 
a number of perspectives; antenatal, labour management, resuscitation of the neonate 
and the overall clinical management of this cohort. This will inform the development 
of best practice national guidelines, assurance of best practice, and evaluation of 
interventions. There is also the possibility that causative and maternal risk factors will be 
identified. This may facilitate the mitigation of these risk factors in the antenatal period. 
Identification of trends in the data will also encourage further enquiry which may impact 
on practices. 
Further, we would like to acknowledge the staff in NPEC. Their professionalism, 
assistance and knowledge has been instrumental in getting this report published. We 
look forward to continuing our work with NPEC in order to establish the E-Register.
Lastly, we would like to extend our thanks to the steering committee for their 
involvement, dedication, expertise and support. 
 
Prof John Murphy Dr Peter McKenna  Prof Richard Greene 
Consultant Neonatologist Consultant Obstetrician  Consultant Obstetrician
National Clinical Lead  National Clinical Director  Director
NCPPN NWIHP NPEC
Foreword
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This report contains maternal and infant data 
pertaining to Neonatal Therapeutic Hypothermia 
(TH) in Ireland for the period of 2016/2017. 
Anonymised data was collected on maternal 
characteristics, history of antenatal care 
and delivery. Data were collected on infant 
characteristics, resuscitation, assessment, hospital 
transfers, their 72-hour clinical course, rewarming, 
feeding and outcomes.
There were 63 cases of TH in 2016 and 77 cases of 
TH in 2017; total of 140 in the two-year period. This 
suggests that one in 900 infants born in Ireland 
during 2016/2017 required TH. The survival rate 
for the TH cohort was 88%, as 17 of the 140 infants 
died.
Of the range of maternal characteristics examined, 
parity showed some evidence of being associated 
with increased risk of the infant requiring TH. 
Almost 40% of all infants born in Ireland are born 
to nulliparous women, whereas this was the case 
for 60% of the TH cohort. Based on available 
examinations, placental conditions were present for 
the vast majority of the infants indicating evidence 
of fetal compromise before delivery.
There was an overrepresentation of complications 
preceding and during the delivery of the infants. 
Many of these complications occur in the labour 
ward including uterine rupture, shoulder dystocia 
and maternal pyrexia during labour alongside an 
overrepresentation of complex modes of delivery.
While these findings support the existing evidence 
that hypoxia requiring TH is caused by antepartum 
and intrapartum complications and events, 
disentangling the role of these complications and 
events requires more extensive data and analysis, 
in particular relating to labour. The fact that TH is 
rare in babies delivered by elective section (1.4%) it 
is likely that the events of labour play an important 
role in the aetiology of this condition.
In Ireland, TH is administered in four centres 
(National Maternity Hospital, Rotunda, Coombe 
Women and Infants University Hospital and Cork 
University Maternity Hospital). Infants born outside 
of these centres must be transferred. Forty percent 
of the TH cohort in 2016/2017 were born in a 
local or regional hospital and were subsequently 
transferred to a tertiary centre. 
Practice guidelines state that TH should be started 
within six hours of birth. This report illustrates the 
logistical challenges faced with the delivery of a 
high acuity, uncommon treatment that has to be 
delivered on short notice. 
The proportion of TH infants requiring intubation 
at delivery was 59%. Additionally, 66% of the TH 
infants had a cord pH of ≤7.0 which underlines the 
severity of the asphyxia for many cases. On Day 
1 of TH therapy, 29% of TH infants experienced 
clinical seizures and 36% of TH infants experienced 
electrographic seizures. During this 24 hour period, 
37% of infants given anticonvulsants. 
Sarnat grade scores, which quantify the level of 
encephalopathy, were not uniformly recorded but 
the available data indicated that 20%, 55% and 25% 
of the TH cohort had mild, moderate and severe 
encephalopathy, respectively.
The effectiveness of TH in preventing brain 
damage to hypoxic neonates is a welcome 
development- though the number needed to treat 
(NNT) remains at 7 i.e. only 1 in 7 will benefit from 
the therapy. A future aspiration is the prevention/
reduction of the condition that necessitates 
cooling i.e. the avoidance of neonatal hypoxic 
ischemic encephalopathy (HIE). 
The consequences of neonatal encephalopathy 
(NE) for the infant, their family and the wider 
society are considerable. Any information that 
signposts the way to avoid such outcomes is to be 
welcomed.
The next steps for this project include the 
development of the E-register in collaboration with 
NPEC. In the interim the process of data collection 
will recommence reviewing maternal and infant 
charts anonymously for the 2018 report.
Executive Summary
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 Key Findings
•  In 2016/2017, 140 infants were treated with TH, suggesting that 
TH is provided to one in 900 infants born in Ireland.
•  Nulliparous mothers accounted for 60% of the TH cohort. 
•  34% of the TH cohort had their labour induced, compared to 
29% of all deliveries in Ireland for 2016. In this report nulliparous 
women were twice as likely to have their labour induced as 
compared with parous mothers in the TH cohort. 
•  Caesarean Section was the most common mode of delivery for 
all 140 infants accounting for 47% of deliveries. Of which:
 – 1.4% of mothers had an elective section.
 –  47% of mothers in the TH cohort had a Caesarean Section 
pre-labour.
 – 53% of Caesarean Sections occurred after the onset of labour. 
•  There were 18 (13%) documented cases of shoulder dystocia.
•  66% of the infants had a cord pH ≤7.0. 
•  79% of the infants had an Apgar score of 0-3 at 1 minute of life.
•  59% of the TH infants required intubation at birth.
•  40% of the TH infants were born in a regional or local hospital 
of which 89% were transferred by the National Neonatal 
Transport Programme (NNTP). 
•  Data for Sarnat grading was incomplete in this report for both 
during TH and upon discharge.
•  A specific placental pathology was present in 83% of cases 
where a placental examination was completed.
•  There was an 88% survival rate amongst the infants who 
received TH in 2016/2017. Of the infants who passed away data 
were not collected on autopsy or post mortem results. As such, 
their cause of death is unknown. 
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1.  Ongoing national review of therapeutic 
hypothermia infant cases is required. 
  Ongoing national audit on the provision 
of care for these infants is warranted. 
The audit tool and dataset need to be 
continually assessed in order to ensure that 
it is capturing the appropriate indicators 
influencing outcomes of care.
2.  Development of a national E-Register 
of all infants treated with therapeutic 
hypothermia.
  The development of the national E-register 
will facilitate benchmarking against 
international registries and databases. 
Such a register will also be well placed 
to evaluate new adjunctive therapies 
such as erythropoietin. Consequently, the 
establishment of the national E-register will 
contribute to a body of evidence which will 
inform standardised clinical practice, public 
health interventions, service planning and 
counselling of prospective parents. 
3.  Regular training updates and drills are 
necessary to ensure optimum management 
of complex obstetric situations. 
  International evidence indicates that shoulder 
dystocia is associated with prolonged 
labour and thus is a risk factor for HIE. The 
current report reflects these findings, with 
13% of deliveries complicated by a shoulder 
dystocia. Training on the management 
of shoulder dystocia and other complex 
obstetric situations is warranted.
4.  All therapeutic hypothermia infants require 
daily Sarnat grading assessment.
  HIE classification is mild/moderate/severe. 
Assessment of the infant’s encephalopathy 
determines the magnitude of injury and 
prognosis. The Sarnat grading scale (Grade 
1 /Grade 2 /Grade 3) is an internationally 
recognised classification assessment tool for 
HIE in the newborn infant. The TH report for 
2016/2017 cases yielded incomplete data for 
Sarnat scoring on TH day 1, 2 & 3.
5.  The start time of either active or passive 
cooling should be documented. However 
the 72 hour treatment clock begins when 
the infant reaches the targeted 33-34°C 
rectal temperature.
  On 35/137 (26%) occasions the 72 hour period 
of cooling was instigated by staff despite 
the infant not being within the optimal rectal 
temperature range of 33-34°C.
6.  All therapeutic hypothermia infants require 
Cranial Ultrasounds to be carried out within 
the first four days of life.
  Cranial ultrasounds are a standard of care for 
TH babies and should be carried out within 
the first 4 days of life.
7.  The development and implementation of 
a standardised review tool for perinatal 
events is advocated.
  A standardised review tool for perinatal 
events which incorporates a comprehensive 
review of adverse outcomes using a 
multidisciplinary team approach will enable 
the identification of potential risk factors for 
pregnant women. 
8.  Placental pathology examination is required 
in all therapeutic hypothermia infants.
  Following the birth of an infant requiring 
TH the placenta should be sent to the 
pathology department and examined by 
a Perinatal Pathologist. In cases where an 
infant is not born in a tertiary hospital, the 
placenta should be stored appropriately and 
accompany the infant when transferred. 
9.  All therapeutic hypothermia infants 
should have a formal neurodevelopmental 
assessment using the 3rd Ed. Bayley 
assessment at 2 years of age. 
  For this report the 2 year follow-up on 
2016/2017 TH infants has not been reviewed. 
However, for the E-register there will be a 
dataset to review and document the formal 
follow up assessment. The optimal timing 
is 2 years of age. The TH centre where the 
infant was managed should coordinate this 
assessment.
Recommendations
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Introduction
The NCPPN in collaboration with NPEC presents its first report on Neonatal 
Therapeutic Hypothermia in Ireland. To date, there had been no national 
overview of the current status and outcomes of Therapeutic Hypothermia (TH) 
in Ireland which represented a dearth in the knowledge available to clinicians, 
health managers and parents. 
This is the first national investigation of TH and incorporates comprehensive 
data on every infant who underwent TH in the years 2016 and 2017 in Ireland. 
It aims to deliver a national overview of TH in Ireland by documenting the 
number of cases in 2016/2017 and collecting baseline data on the maternal, 
infant and clinical characteristics associated with TH. 
Secondly, the current project aims to inform the development and 
implementation of a National Therapeutic Hypothermia E-Register for Ireland. 
A national E-register encompassing data on all cases of TH in Ireland will 
serve as a platform for identification of maternal, infant and clinical risk 
factors associated with the requirement for TH intervention; development of 
best practice guidelines; and identification of trends over time. Furthermore, 
a national E-register will facilitate benchmarking of TH in Ireland against 
international standards and thus ensure continual quality improvement. 
Section 1 of this report contains the main maternal findings including;
• Maternal characteristics
• Maternal antenatal course 
• Labour
• Delivery
Section 2 of this report contains the main infant findings including;
• Infant Characteristics
• Resuscitation
• Assessment for Therapeutic Hypothermia
• Transfer to tertiary unit
• Treatment days 1-3
• Rewarming
• Feeding
• Discharge diagnosis and neonatal death 
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Purpose of this report
The primary aim of this report is to present an overview and national statistics on Neonatal 
Therapeutic Hypothermia in the Republic of Ireland for the years 2016 and 2017. Therapeutic 
Hypothermia (TH) is administered in four centres only (National Maternity Hospital, 
Rotunda, Coombe Women and Infants University Hospital and Cork University Maternity 
Hospital). All infants born in other local and regional hospitals needing this treatment are 
transferred to one of these four centres. 
The audit will examine the clinical details around each case of Neonatal Therapeutic 
Hypothermia. This will include the mothers’ antenatal details, labour, delivery, resuscitation, 
neurological assessment, treatment of seizures, the supportive clinical care the examination 
of the placenta and post mortem, if applicable.
Data Collection
Retrospective reviews of inpatient medical records have been used as a gold standard 
approach when assessing multiple outcomes and rates of adverse events. Therefore, for 
the purposes of the National Neonatal Therapeutic Hypothermia Audit, medical records 
were considered the primary source of information. Data were collected on site in the 
19 maternity units/hospitals and neonatal intensive care units or special care baby units 
(NICU/SCBU) in the Republic of Ireland. The NCPPN and NPEC collected data on all 
cases of neonatal therapeutic hypothermia in 2016 and 2017 by taking an active case 
ascertainment approach. 
Processing of the data
Data on all infants who received therapeutic hypothermia were collected on site in the 
19 maternity units/hospitals. The data were submitted by paper to the NPEC and were 
processed in a pseudonymised format. No hospital identifiers were included in the dataset, 
which means these data cannot be attributed a specific hospital or a specific individual. 
Missing data 
To ensure accuracy of information, missing or incomplete data were sought from the 
respective maternity hospitals/units by the Therapeutic Hypothermia Co-Ordinator. For 
analysis purposes, cases with missing data were excluded from calculations. However, the 
extent of missing data is reported in the results section.
Comparison to National Statistics
Comparisons are made with the most recent publications available, including the Central 
Statistics Office’s Vital Statistics Fourth Quarter and Yearly Summary report as well as from 
the Healthcare Pricing Office. 
Methods
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Definitions & Terminology
Neonatal Encephalopathy (NE) is a clinical condition in the term infant defined by 
abnormal neurological behaviour, with the onset occurring at or shortly after birth. 
NE is manifested by an abnormal level of consciousness, with or without the 
presence of seizures and is often accompanied by difficulty initiating and maintaining 
respirations, depressed tone and depressed reflexes, poor suck and swallow. 
NE incidence is estimated as 3.0 per 1000 live births and for HIE is 1.5.1 NE is graded as 
mild, moderate or severe using the Sarnat grading system. 
A subgroup of infants with NE have been exposed to a hypoxic-ischaemic insult 
in-utero and therefore they are assigned a diagnosis of hypoxic-ischaemic 
encephalopathy. In a proportion of these cases, a sentinel event is identified i.e. 
placental abruption, uterine rupture etc. 
Suggested criteria for an intrapartum hypoxic-ischaemic insult2 include: 
(i)  Evidence of metabolic acidosis in fetal umbilical cord arterial blood obtained at 
delivery (pH < 7 and base deficit ≥ 12 mmol/L).
(ii)  Early onset of severe or moderate NE in infants ≥ 34/40.
(iii)  A sentinel hypoxic event occuring immediately before or during labour e.g. 
uterine rupture, placental abruption, cord prolapse etc.
(iv)  A sudden and sustained fetal bradycardia or the absence of fetal heart rate 
variability in the presence of persistent late or persistent variable decelerations 
on cardiotocography, usually after a hypoxic sentinel event when the pattern was 
previously normal.
(v)  Apgar scores of 0-3 beyond 5 minutes.
(vi)  Onset of multisystem involvement within 72 hours of birth.
(vii)  Early imaging study showing evidence of acute non-focal cerebral abnormality.
(viii)  Exclusion of other identifiable aetiologies e.g. trauma, coagulation disorders, 
infection or genetic disorders. 
TH has been found to be protective in those infants presenting with moderate or 
severe HIE by inhibiting various events in this cascade of HIE injury. Major randomized 
clinical trials3-5 involving induced neonatal hypothermia have demonstrated a 
reduction in death and disability.6-8 These trials have shown improved outcomes for 
babies with HIE if they are cooled within six hours of birth to a targeted core body 
temperature of between 33°C to 34°C for a duration of 72 hours. Rewarming to 
normothermic temperature occurs over a 6-12 hour period. TH is considered to be the 
standard of care for infants with moderate-to-severe HIE who meet inclusion criteria.
The inclusion criteria for TH are;
•  >36 weeks completed gestation with a weight ≥ 1800grams.
•  Acidosis (pH<7.0) present in the umbilical cord, or any blood sample taken within 
60 minutes of birth.
•  Base deficit ≥ -16.0 mmol/L in umbilical cord or any blood sample taken within 60 
minutes of birth.
•  History of acute perinatal event (such as but not limited to cord prolapse, placental 
abruption or uterine rupture).
•  Apgar score ≤5 at 10 minutes or at least 10 minutes of positive-pressure ventilation.  
•  Evidence of moderate-to-severe encephalopathy, demonstrated by the presence 
of seizures OR at least one sign in three or more of the six categories shown In the 
Modified Sarnat Table (see Table 35).
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Main Findings




The age of mothers whose infants underwent therapeutic hypothermia was known for all 
140 mothers in the years, 2016 and 2017. The mothers whose infants underwent therapeutic 
hypothermia ranged in age from teenage years (the youngest 18 years of age) through to 
early-forties (43 years of age). Their age distribution broadly reflected that of the population 
of mothers who gave birth in Ireland in 2016 (Table 1). There was a higher proportion of 
mothers aged 20-24 years (11.4%) whose babies were cooled, than of mothers who gave birth 
in 2016 (7.9%). Over half of the population (52.3%) who gave birth in 2016 were aged 25-34 
years, whereas a slightly lower proportion of mothers whose infants underwent therapeutic 
hypothermia were in this age group (50.7%). 
Table 1: Age distribution of mothers whose infants underwent therapeutic hypothermia in 2016 
or 2017 versus all births in 2016
Age group
TH cases  
N=140  
2016/2017








≥ 40yrs 9(6.4) 6.7%
Note: Values are shown as N(%) unless otherwise stated.
Ethnicity
Assessment of risk associated with ethnic group is impeded by the absence of national data on 
ethnicity for the pregnant population in Ireland. The majority of mothers whose infants underwent 
therapeutic hypothermia were of white Irish ethnicity (76.1%) (Table 2). This is similar to the 
proportion of white Irish women in the female population aged 15-49 years enumerated by the 
National Census 2016. While the numbers involved were small, Irish Traveller and Asian ethnicities 
were overrepresented in the mothers whose infants underwent therapeutic hypothermia in 2016 
or 2017 (6.5%) compared to 3.6% of the female 15-49-year-old population in 2016.
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Table 2: Ethnicity of mothers whose infants underwent therapeutic hypothermia in 2016 or 2017 





15-49 year-old  
female population, 2016** 
(%)
White Irish 105(76.1) 79.2
Irish Traveller 2(1.4) 0.7
Other white background 20(14.5) 13.7
Asian/Asian Irish 7(5.1) 2.9
Black/Black Irish 4(2.9) 1.7
Other/mixed 0(0.0) 1.9
Note: Values are shown as N(%) unless otherwise stated.  
*Ethnicity unknown for two mothers. **Population data from the National Census 2016.
Occupation
Table 3 provides a high-level overview of the data that were provided on mother’s occupation, 
alongside data available for the most comparable occupation categories for mothers of all births in 
Ireland9 and for the 15-44 year-old female population from the National Census 2016. Employment 
status was specified for 84.3% of the mothers for whom data were recorded (Table 3). It can be 
seen that unemployed status was recorded for 9.3% of the mothers whose infants underwent 
therapeutic hypothermia compared to 4.5% of all mothers and 8.2% of the female population 
aged 15-44 years. The proportion of mothers engaged in home duties whose infants underwent 
therapeutic hypothermia (7.6%) was lower than the percentage of all women engaged in home 
duties who gave birth (20.5%) in 2016 but was similar to the proportion of females aged 15-49 
years in the Irish population.
Table 3: Occupation at booking of mothers whose infants underwent therapeutic hypothermia in 








15-44 year-old  
female population, 2016* 
(%)
Employed 91(77.1) 73.1 57.8
Unemployed 11(9.3) 4.5 8.2
Home duties 9(7.6) 20.5 10.4
Student 7(5.9) n/a 21.1
Others not in labour force 0(0.0) n/a 2.5
Note: *Data not known on employment for 22 mothers. **Population data from Census 2016.
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Body Mass Index
Body mass index (BMI) was available for 134 of the 140 of women whose infants underwent therapeutic 
hypothermia in 2016 or 2017 (Table 4). The pattern of BMI in the mothers was similar to that in the 
women from the general population who participated in the 2015 Healthy Ireland Survey10. The BMI 
of 25.4% of these mothers was in the obese range (≥30.0kgm-2) which is slightly higher compared to 
women from the general population.
Table 4: Body mass index of mothers whose infants underwent therapeutic hypothermia in 2016 or 
2017 versus female participants in the Healthy Ireland Survey in 2015
BMI Category  
(kg/m2)
TH cases  
N=134*  
2016/2017
Healthy Ireland   
Survey 201510 
Underweight (<18.5) 3(2.2) 3%
Healthy (18.5-24.9) 55(41.0) 44%
Overweight (25.0-29.9) 42(31.3) 31%
Obese (≥30.0) 34(25.4) 22%
Note: Values are shown as N(%) unless otherwise stated. *BMI value missing for six mothers.
Smoking and substance abuse
Smoking status of the mothers at their time of booking was recorded for 137 (97.9%) of the 140 women. 
Of these, 10 (7.3%) were smokers at the time of booking. Information on smoking was available for 
eight of the ten smokers (80.0%). Six women were smoking between 1 and 9 cigarettes per day (n=6 
of 8, 75.0%) and two were smoking 10 or more cigarettes per day (n=2 of 8, 25%). Of the eight women 
who were smoking at booking, three (37.5%) stopped smoking during pregnancy. There were no 
pregnancies with a documented history of alcohol abuse but one woman had a documented history of 
drug abuse.
Previous pregnancy 
In terms of parity of women who delivered infants requiring therapeutic hypothermia in 2016 and 2017, 
there was an overrepresentation of women who had not previously delivered (60.0%) compared to the 
general population of women who gave birth in 2016 (38.2%; Table 5).
Table 5: Distribution of parity, 2016-2017
Parity







Para 1 34(24.3) 34.9
Para 2 13(9.3) 17.9
Para 3+ 9(6.4) 9.0
Note: Values are shown as N(%) unless otherwise stated.
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Over half of mothers whose infants underwent therapeutic hypothermia in 2016 or 2017 had at least 
one previous pregnancy (gravida > 0; 75 of 140, 53.6%). Table 6 specifies gravida/parity for 139 of the 
140 women whose infants underwent neonatal therapeutic hypothermia in 2016 or 2017. Nearly half 
(n=65, 46.8%) had never been pregnant before (gravida = 0). Of the 74 women who had been pregnant 
(gravida > 0), 40.5% (n=30) had pregnancies exceeding 24 weeks or 500g birthweight (gravida = parity, 
indicated by green shading). Over one third of these 74 mothers (n=25, 33.8%) experienced at least one 
pregnancy exceeding 24 weeks or 500g birthweight and at least one pregnancy less than 24 weeks 
gestation and under 500g birthweight (gravida > parity > 0, indicated by yellow shading). Additionally, 
one quarter (25.7%, n=19) of these women’s previous pregnancies never exceeded 24 weeks gestation or 
500g birthweight (gravida > parity = 0, indicated by orange shading).








0 1 2 3 4 5 6 7 8 9 Total
0 65 0 0 0 0 0 0 0 0 0 65
1 14 19 0 0 0 0 0 0 0 0 33
2 2 11 8 0 0 0 0 0 0 0 21
3 3 2 3 0 0 0 0 0 0 0 8
4 0 0 2 0 1 0 0 0 0 0 3
5 0 0 0 1 2 0 0 0 0 0 3
6 0 1 0 1 1 0 1 0 0 0 4
7 0 0 0 0 0 0 0 0 0 0 0
8 0 0 0 0 0 0 0 0 0 0 0
9 0 0 0 0 0 0 0 1 0 1 2
10 0 0 0 0 0 0 0 0 0 0 0
11 0 0 0 0 0 0 0 0 0 0 0
Total 84 33 13 2 4 0 1 1 0 1 139
Note: We refer to gravida and parity prior to the pregnancy associated neonatal therapeutic hypothermia. Green 
represents women with previous pregnancies that were all ≥24 weeks or ≥500g; yellow represents women who had 
experienced pregnancy ≥24 weeks or ≥500g and also pregnancy <24 weeks and <500g; and orange represents 
women whose previous pregnancies were always <24 weeks gestation and <500g birthweight.
Of the 75 women who had a previous pregnancy, 37.3% (n=28) were reported to have had a previous 
pregnancy-related problem (undocumented for 7 women). Caesarean section delivery was the most 
common previous pregnancy-related problem with nearly twenty percent of mothers (n=14, 18.7%) 
having a previous caesarean section delivery (Table 7). Three or more miscarriages was the second 
most common, with 6.7% (n=5) of mothers experiencing this in a previous pregnancy. Infant requiring 
intensive care (n=3, 4.0%) was the third most common pregnancy-related problem in mothers who had 
a previous pregnancy. None of the mothers had an infant with HIE in a previous pregnancy.
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Table 7: Previous pregnancy-related problems in mothers whose infants underwent therapeutic 
hypothermia in 2016 or 2017
TH cases  
2016/2017  
N=75 
Previous caesarean delivery 14(18.7)
Three or more miscarriages 5(6.7)
Infant requiring intensive care 3(4.0)





Infant with congenital anomaly 0(0)
Placenta praevia 0(0)
Post-partum haemorrhage requiring transfusion 0(0)
Previous infant with HIE 0(0)
Note: Percentage relates to total number of mothers who had a previous pregnancy (n=75).  
Categories are not mutually exclusive. Values are shown as N(%) unless otherwise stated.
Pre-existing medical problems
One in three of the women, whose infants underwent therapeutic hypothermia in 2016 or 2017, had 
a pre-existing medical problem (n=43, 30.7%). Thirty-two of the 140 women were taking prescribed 
medication during the pregnancy (22.9%). Four mothers had a documented family history of conditions 
which can affect newborn infants (2.9%, n=4). The most common type of pre-existing medical problems 
were the Endocrine disorders, with 7.1% of mothers (n=10) suffering from conditions of this type (Table 
8). Psychiatric disorders had the second highest percentage of occurrence (5.0%, n=7). Asthma was also 
common among women (5.0%, n=7).
Table 8: Pre-existing medical problems in mothers whose infants underwent therapeutic  
hypothermia in 2016 or 2017














Note: Percentage relates to total number of mothers (n=140). Categories are not mutually exclusive. 
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Antenatal care 
Fertility treatment 
Currently in Ireland there is no national data on the number of births as a result of fertility treatment. 
Information was available for 137 of the 140 (97.9%) whose infants underwent therapeutic hypothermia 
in 2016 or 2017. In nine of these cases (6.6%) the pregnancy was reported to be the result of fertility 
treatment. In vitro fertilisation was the method of fertility treatment specified for all nine pregnancies.
During this pregnancy, the majority of the 140 women intended on delivering in an obstetric unit (99.3%; 
n=139) with obstetric-led care (96.4%; n=135). One-quarter of women had an antenatal ultrasound scan 
before 12 weeks gestation (27.1%; n=38) and two thirds of the women had a scan between 12 and 19 
weeks gestation (67.1%; n=94). Gestation at booking was unknown for four women (Table 9). Estimated 
date of delivery (EDD) was documented for 139 of the 140 women. EDD was calculated using ultrasound 
scan in the majority of cases (91.4%; 127 of 139). 
Table 9: Timing of antenatal hospital booking appointment for mothers whose infants underwent 
therapeutic hypothermia in 2016 or 2017
TH cases  
2016/2017  
N=140 
Less than 12 weeks 38(27.1)
12-19 weeks 94(67.1)
20 weeks of later 4(2.9)
Unknown 4(2.9)
Note: Values are shown as N(%) unless otherwise stated. 
Gestation at last antenatal hospital visit
Information on the last antenatal visit was available for 136 of the 140 women whose infants underwent 
therapeutic hypothermia in 2016 or 2017 (97.1%). These 136 women last attended the hospital clinic 
between 32 and 41 weeks. Almost 90% attended at 36 weeks or later (88.2%, n=120) with 11.8% (n=16) last 
attending the hospital before the last routine preterm antenatal clinic visit at 36 weeks gestation (Figure 1). 
Of the 140 women, two (1.4%) were transferred from another maternity unit with the fetus in utero at 35 
and 40 gestational weeks respectively.
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Concern documented during pregnancy
Of the 140, there were concerns documented during the pregnancy for 53 of the mothers whose infants 
underwent therapeutic hypothermia in 2016 or 2017. The most common concern documented was women 
who developed hypertensive disorders during pregnancy with 9.3% of mothers (n=13) suffering from 
conditions of this type. This was followed by gestational diabetes mellitus which had second the highest 
percentage of occurrence (7.8%, n=11). Polyhydramnios was also common occurring in 6.4% (n=9) of these 
pregnancies. 
Labour 
Information on the onset of labour was available for all 140 women whose infants underwent therapeutic 
hypothermia (100%). Almost half of the women laboured spontaneously (49.3%; n=69), over a third of 
women were induced (34.3%; n=48) and 16.4% of women were never in labour (Table 10). Nulliparous 
women were twice as likely to be induced as parous women. Parous women were four times more likely 
never to labour than nulliparous women. Almost half of the women who laboured spontaneously had their 
labour accelerated (43.5%; n=30 of 69) either by artificial rupture of membranes (ARM; 56.7%, n=17 of 30) 
or syntocinin (43.3%; n=13 of 30). As indicated in Table 11, nulliparous women were much more likely to 
have their labour accelerated with syntocinin than parous women (66.7% versus 8.3%).







Spontaneous 69(49.3) 32(49.2) 37(49.3)
Induction 48(34.3) 29(44.6) 19(25.3)
Never in labour 23(16.4) 4(6.2) 19(25.3)
Note: Values are shown as N(%) unless otherwise stated.







ARM 17(56.7) 6(33.3) 11(91.7)
Syntocinin 13(43.3) 12(66.7) 1(8.3)
Note: Values are shown as N(%) unless otherwise stated.
As outlined in Table 12, liquor was clear in 68 of the 111 documented cases (61.3%). A quarter of women 
had meconium stained liquor (27.9%; n=31). The grade of meconium was specified for 24 of the 31 of these 
cases (77.4%) with 50% (n=12) of women having Grade 1, 41.7% (n=10) of women having Grade 2 and the 
remaining two women having Grade 3 (8.3%).







Note: Values are shown as N(%) unless otherwise stated. Categories are not mutually exclusive. 
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There was a documented reason for induction for 44 of the 48 women who were induced. As indicated 
in Table 13, the common reasons to induce labour were associated with post maturity (20.5%; n=9), 
reduced fetal movement (13.6%; n=6), hypertensive disorders (11.4%; n=5) and polyhydramnios (11.4%; 
n=5). Under the “Other” category a wide range of indications were captured including, but not limited 
to, fetal tachycardia, cardiotocograph traces (CTG) not meeting reassuring criteria, twins, antepartum 
bleeding and oligohydramnios. 






Reduced Fetal Movements (RFM) 6(13.6)
Hypertensive disorders 5(11.4)
Polyhydramnios 5(11.4)
Large for dates 4(9.1)




Note: Values are shown as N(%) unless otherwise stated. Categories are not mutually exclusive.
The method of induction was known for 47 of the 48 women who were induced (97.9%). The majority of 
women had their labour induced using multiple methods of induction (72.3%; 34 of 47). As illustrated in 
Table 14, the most common method of induction was the use of oxytocin (61.7%; n=29), followed by ARM 
(57.4%; n=27) and half of women had their labour induced with prostin (51.1%; n=24).








Oxytocin 29(55.3) 18(62.1) 11(61.1)
Artificial rupture of membranes 27(57.4) 16(55.2) 11(61.1)
Prostin 24(51.1) 16(55.2) 8(44.4)
Propress 13(27.7) 9(31.0) 4(22.2)
Other 1(2.1) 1(3.4) 0(0)
Note: Values are shown as N(%) unless otherwise stated. Categories are not mutually exclusive.
Fetal heart monitoring was undertaken for 110 of the 140 women whose infants underwent therapeutic 
hypothermia (78.6%). The method of fetal heart monitoring was documented for 108 of the 110 women 
(98.2%). As illustrated in Table 15, external continuous fetal heart monitoring was the most common 
method of monitoring used during labour (79.6%; n=86 of 108). Four women who had external 
continuous fetal heart monitoring also had internal continuous fetal heart monitoring undertaken (4.7%; 
n=4 of 86). A third of women were had external intermittent fetal heart monitoring (37.0%; n=40 of 108). 
Of these women, almost half also had external continuous fetal heart monitoring undertaken during 
labour (47.5%; n=19 of 40).
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Table 15: Method of fetal heart monitoring for infants who underwent therapeutic hypothermia 







Note: Values are shown as N(%) unless otherwise stated. *Data on fetal heart monitoring was missing for two 
women. Categories are not mutually exclusive.
Data on CTG were available for 104 of the 140 cases (74.3%). Of these 104, almost half were 
interpreted as suspicious (44.2%; n=46) and pathological in a quarter of cases (26.9%; n=28). 
A fetal blood sample was taken for 21 of the 140 infants underwent therapeutic hypothermia 
in 2016 or 2017 (15.0%). Fetal blood samples were more likely to be taken for infants with a 
suspicious CTG (21.7%; n=10 of 46) or a pathological CTG (28.6%; n=8 of 28) compared to those 
with a normal CTG (11.5%; n=3 of 26). All infants had a pH greater than 7.0 (Range: 7.1-7.5) from 
the initial fetal blood sample and the median base deficit was 2.7 (Range: 0.50-28.5). 
Delivery
The type of care received at delivery was known for all mothers whose infants underwent 
therapeutic hypothermia (n=140). The vast majority of the infants (97.1%; n=136) were delivered 
under obstetric-led care which is the predominant model of care in Ireland. One baby was 
delivered at home under midwifery-led care, one baby was born in a general hospital and two 
babies were born before arrival at the maternity unit. 
Presentation at delivery was known for 95.0% of mothers whose infants underwent therapeutic 
hypothermia (n=133 of 140). The majority of presentations at delivery were vertex presentations 
(n=123 of 133, 92.5%) and in ten cases, the presentation was breech (n=10 of 133, 7.5%). Mode of 
delivery was known for all mothers (n=140) whose infants underwent therapeutic hypothermia 
(Table 16). A third of the deliveries were instrumental (31.4%, n=43). Of the women who had an 
instrumental delivery, 14 mothers who had a ventouse delivery also had a forceps delivery. The 
interval time from decision to the instrumental delivery was known in 41 of the mothers. The 
median interval time to delivery was 16 minutes and ranged from two to 85 minutes. 
Infants whose CTG was interpreted as suspicious or pathological were more likely to have an 
operative birth rather than a spontaneous vaginal delivery. Approximately twenty percent of 
infants had a spontaneous vaginal delivery (22.1%, n=31), which is considerably lower than the 
proportion of vaginal deliveries of all births occurring in 2016 (52.2%).
Caesarean section was the most common mode of delivery for all 140 of these infants (47.1%, 
n=66), with a small percentage more of caesarean sections happening after the onset of labour 
(53.0%, n=35 of 66) rather than pre-labour (47.0%, n=31 of 66). Two of mothers whose infants 
underwent therapeutic hypothermia in 2016 or 2017 had an elective caesarean section (1.4%).
Three mothers had a caesarean section following a failed instrumental delivery. Emergency 
caesarean section delivery was the most common type of caesarean section delivery, accounting 
for 89.4% of cases where the infant was delivered by caesarean section (n=59 of 66). 
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Table 16: Mode of delivery for mothers whose infants underwent therapeutic hypothermia in  
2016 or 2017
TH cases 2016/2017 N=140 All births 20161










Assisted breech 0(0) Assisted breech 0.5%
Ventouse** 41(29.3) Ventouse 11.1%
Forceps 19(13.6) Forceps 3.6%
Note: Values are N(%) unless otherwise stated. Categories are not mutually exclusive. 
+Vaginal births in this category include women who had both a Spontaneous Vaginal Cephalic and a Spontaneous 
Vaginal Breech delivery. 
++Caesarean section in this category include women who had a pre-labour caesarean section as well as women who 
had a caesarean section after the onset of labour. 
*Three mothers had a caesarean section following failed instrumental deliveries. 
**14 mothers who had a ventouse delivery, also had a forceps delivery.
Other incidences at birth and following delivery
As outlined in Table 17, 18.6% of women whose infants underwent therapeutic hypothermia experienced 
maternal pyrexia during labour (n=26). One in ten women had a prolonged rupture of membranes (10%, 
n=14). 





Maternal pyrexia in labour 26(18.6)
Shoulder dystocia 18(12.9)
Prolonged rupture of membranes 14(10.0)
Subgaleal haematoma 3(2.1)
Spontaneous premature labour 1(0.7)
Birth trauma 1(0.7)
Fracture 0(0)
Premature rupture of membranes 0(0)
Other 20(14.3)
Note: Values are shown as N(%) unless otherwise stated. Categories are not mutually exclusive.
Uterine rupture
Over the two year period, there were five reported cases of uterine rupture which equates to a rate of 
37.5 per 1,000 within this cohort. This rate is significantly higher than the incidence of uterine rupture 
in the Irish general population which has consistently been reported at 0.14 per 1,000 maternities since 
201111. All five women who experienced uterine rupture were parous. One woman was reported to have 
had a caesarean section in a previous pregnancy. Two of the women had an elective caesarean section in 
this pregnancy, with three women having a caesarean section after the onset of labour. The birth weight 
for these infants ranged from 2820 grams to 4260 grams. 
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Shoulder dystocia infants
During delivery of the 140 infants, there were 18 reported incidents of shoulder dystocia (12.9%). This 
rate is 9 times higher than that which is reported for all deliveries (1.4%) in high-income countries12. Of 
18 reported incidents of shoulder dystocia, three-quarters of the women were nulliparous (77.8%; n=14 
of 18). Eight of these 18 women had an induction of labour (Table 18) and seven of the women who 
laboured spontaneously had their labour accelerated. 
Of the 18 women, 14 of the women had an instrumental delivery (77.8%; n=14 of 18). The median interval 
time between decision and delivery was 21.5 minutes, ranging from 13 to 35 minutes. Of the 14 women 
who had an instrumental delivery, nine women (64.3%; n=9 of 14) had their birth assisted with ventouse, 
with three women (21.4%; n=3 of 14) having a combination of ventouse and forceps. 
The most common manoeuvre utilised for all deliveries was a combination of McRoberts and 
Suprapubric pressure (55.6%; n=10 of 18). The birth weight for these infants ranged from 3,040 grams to 
5,340 grams, with a third of these infants (38.9%; n=7 of 18) weighing 4,000-4,499 grams.
Table 18: Maternal and Infants characteristics for deliveries with a reported shoulder dystocia















Induction of labour 8(44.4)
Mode of delivery











Note: Values are shown as N(%) unless otherwise stated. 
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Infant characteristics
Over half of the infants who received therapeutic hypothermia were male (57.1%; n=80). In the overall 
population of births in 2016, 51.3% were male and 48.7% female (Table 19). There were six infants who 
underwent therapeutic hypothermia from multiple births (4.3%). This is similar to the proportion of 
multiples among all births in 2016 (3.8%).9







Note: Values are shown as N(%) unless otherwise stated. 
Gestation at delivery
Figure 2 outlines the gestational age at delivery for infants who underwent therapeutic hypothermia 
in 2016 or 2017 versus all infants born in 2016. The majority of infants were born between 36 and 41 
completed weeks gestation (88.6%; n=124). Seven infants were born between 32 and 35 completed 
weeks (5.0%), these seven infants had a birthweight greater than 1,800 grams.
Figure 2: Gestational age at delivery (weeks) for infants who underwent therapeutic hypothermia 






















Gesational age at delivery (weeks)
TH General Population 2016
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Birthweight at delivery
The mean birthweight for infants who underwent neonatal therapeutic hypothermia in 2016 or 2017 
was 3,396 grams (Standard Deviation: 637). The birth weight ranged from 1,810 grams to 5,340 grams. 
As outlined in Figure 3, almost a third of infants weighed 3,000-3,499 grams (29.3%, n=41). Almost 
half of infants weighed 3,500 grams or more (45.0%, n=63). A small proportion of infants weighed 
between 1,800 and 2,499 grams (7.9%, n=11).
Figure 3: Distribution of birthweight for infants who underwent therapeutic hypothermia in 2016 or 
2017 versus all infants born in 2016
Birthweight Centiles
Gestation Related Optimal Weight (GROW) software and coefficients derived from the multiple 
regression analysis of data on 11,072 births in six maternity units in Dublin, Galway, Limerick and Belfast 
in 2008-200913, was used to produce Figure 4, which illustrates the fetal growth in utero of the infants 
who underwent neonatal therapeutic hypothermia in 2016 or 2017.
The optimal weight and normal range for all gestations are plotted with the actual birthweights of the 
infants in Figure 5. For these infants, it can also be seen in Table 20, almost one in five infants were 
below the lower limit of the normal range (10th centile).




















25ANNUAL REPORT 2016 – 2017
Figure 4: Optimal birthweight and normal range compared to actual birthweights for infants who 
underwent therapeutic hypothermia in 2016 or 2017
Figure 5: Distribution of customised birthweight centiles for infants who underwent therapeutic 
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When examined by birth weight centile category the distribution of the TH cohort was broadly 
similar to that expected but there was some evidence of poor fetal growth. Almost 20% of the infants 
(n=26, 18.6%) were below the 10th centile.










Note: Values are shown as N(%) unless otherwise stated. 
Diagnosis of fetal growth restriction (FGR)
Data on diagnosis of FGR were recorded for 137 of the 140 infants that underwent therapeutic 
hypothermia (97.9%). A diagnosis of FGR was reported for 11 (8.0%) of the 137 infants (Table 21). 
An antenatal diagnosis of FGR (as opposed to diagnosis based on observation at delivery or post-
mortem) was reported for 6 of the 11 infants (54.5%).
Table 21: Diagnosis of fetal growth restriction for infants who underwent therapeutic hypothermia 




No diagnosis documented 126(92.0)
Diagnosis of fetal growth restriction 11(8.0)
Fetal growth restriction suspected antenatally 6 of 11(54.5)
Note: Values are shown as N(%) unless otherwise stated. 
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Resuscitation 
Neonatal or paediatric support was called prior to the delivery of the majority of cases (80.7%; n=113 
of 140). As outlined in Table 22, a Registrar was present at the vast majority of births (93.5%; n=129 
of 138; data missing for two infants). A Senior House Officer (SHO) was also present at the majority 
of births (84.1%); n=116. A Neonatal Nurse was present at almost half of births (42.8%; n=59) with a 
Midwife present for one in four births (23.9%; n=33). A Consultant was present for a third of births 
(34.8%; n=48).







Senior House Officer 116(84.1)
Neonatal Nurse 59(42.8)
Midwife 33(23.9)
Note: Values are shown as N(%) unless otherwise stated. *Data missing for two infants.
As indicated in Table 23, at one minute after birth over three quarters of infants (79.7%; n=110 of 138) 
had an Apgar score between zero and three. At ten minutes infants with an Apgar score between 
zero and three had reduced to (19.7%; n=25 of 127). At twenty minutes one fifth of infants had an 
Apgar score of eight or greater (19.0%; n=8 of 42).
Table 23: Apgar Scores at 1, 5, 10 and 20 minutes for infants who underwent therapeutic 









0-3 110(79.7) 57(41.0) 25(19.7) 9(21.4)
4-7 26(18.8) 73(52.5) 76(59.8) 25(59.5)
8-10 2(1.4) 9(6.5) 26(20.5) 8(19.0)
Note: Values are shown as N(%) unless otherwise stated. 
Spontaneous breath was sustained by half of infants (52.9%; n=74 of 140). The age at which 
spontaneous breath was sustained was recorded for 58 of the 140 infants (41.4%) and began between 
1 and 25 minutes (median 5 minutes). 
As illustrated in Table 24, almost all infants required resuscitation (95%; n=133 of 140). Over half of 
the 140 infants needed intubation (59.3%; n=83) which occurred between 1 and 40 minutes (median 
6 minutes). One third of infants required chest compressions (33.6%, n=47), which lasted between 1 
and 25 minutes (data missing for one infant). FIO2 was required for the majority of infants (95.6%, 
n=129 of 135; data missing for five infants). 
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Spontaneous breath taken 74(52.9)
Resuscitation required 133(95.0)
Intubation required 83(59.3)
Chest compression required 47(33.6)
FIO2 required 129(95.6)*
Note: Values are shown as N(%) unless otherwise stated. Categories are not mutually exclusive.  
*Data missing for five infants.
Table 25: Drugs or fluid treatment administered at birth for infants who underwent therapeutic 







O neg blood 13(9.3)
Sodium Bicarbonate 3(2.1)
Note: Values are shown as N(%) unless otherwise stated. Categories are not mutually exclusive.
One of the key indicators for intrapartum asphyxia is severe metabolic acidosis evident in umbilical 
cord blood at delivery.14 As outlined in Table 26, at delivery, half of infants (65.6%, n=84 of 128; data 
missing for 12 infants) had a pH of 7.0 or lower. The median base deficit was 11.6 (Range: 2.90-31.4) 
from cord blood gases and 14.5 (Range: 1.9-33.5) from initial infant blood gases. 
Table 26: pH level from cord and initial infant blood gases for infants who underwent therapeutic 
hypothermia in 2016 or 2017











6.6-6.7 16(12.5) 3(4.8) 4(10.8) 3(9.7) 1(11.1)
6.71-6.8 24(18.8) 5(7.9) 3(8.1) 4(12.9) 1(11.1)
6.81-6.9 25(19.5) 10(15.9) 7(18.9) 2(6.5) -
6.91-7.0 19(14.8) 9(14.3) 5(13.5) 3(9.7) -
7.01-7.1 17(13.3) 13(20.6) 6(16.2) 5(16.1) 3(33.3)
7.11-7.2 15(11.7) 12(19.0) 6(16.2) 8(25.8) 1(11.1)
7.21-7.3 10(7.8) 7(11.1) 4(10.8) 5(16.1) 2(22.2)
7.31-7.4 2(1.6) 4(6.3) 2(5.4) 1(3.2) 1(11.1)
Note: Values are shown as N(%) unless otherwise stated.
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Assessment for Therapeutic Hypothermia
All 140 infants met one or more criteria for therapeutic hypothermia (Table 27). Three quarters of the 
women (76.4%), whose infants underwent therapeutic hypothermia, experienced an acute perinatal 
event. Almost half of infants experienced variable and/or late foetal heart rate decelerations during 
labour (45.7%; n=64). 




>36 completed weeks gestational age 133(95.0)
Apgar score ≤ 5 at 10 minutes 59(42.1)
Weight ≥ 1800 grams 140(100)
Continued need for PPV or Intubation at 10 mins 87(62.1)
Did an acute perinatal event occur? 107(76.4)
Variable / late foetal heart rate decelerations 64(45.7)
Prolapsed / ruptured / tight nuchal cord 18(12.9)
Uterine Rupture 5(3.6)
Maternal haemorrhage / placental abruption 22(15.7)
Maternal trauma 0(0.0)
Other 16(11.4)
Acidosis present in umbilical cord, or any blood sample within 60 minutes of birth 101(72.1)
Base Deficit >16.0 mmol/L in umbilical cord, or any blood sample, within 60 minutes 
of birth
73(52.1)
Note: Values are shown as N(%) unless otherwise stated.
The majority of the infants (83.3%, n=115 of 138; data missing for two infants) had a diagnosis of 
encephalopathy consisting of altered state of consciousness, (lethargy, stupor or coma). A grade of 
encephalopathy was assigned to 69 of the 115 infants (60.0%). Table 28 illustrates that over half of 
infants were graded as moderately encephalopathic during assessment for therapeutic hypothermia 
(56.5%; n=39).







Note: Values are shown as N(%) unless otherwise stated.
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Transfer to Tertiary Unit
Half of all infants who were delivered in Ireland in 2016 were born in a tertiary unit (52%).1 Eighty-four 
of the 140 infants who underwent neonatal therapeutic hypothermia in 2016 or 2017 were born in a 
tertiary hospital (60.0%; Table 29). Fifty-six infants required transfer to a tertiary unit for therapeutic 
hypothermia treatment (40.0%). The majority of infants were transferred with the National Neonatal 
Transport Programme (87.5%; n=49 of 56) with the remaining seven infants transferred by the Health 
Service Executive. 




Inborn at tertiary unit 84(60.0)
Out-born requiring transfer 56(40.0)
Transferred by the National Neonatal Transport Programme 49 of 56(87.5)
Transferred by the Health Service Executive 7 of 56(12.5)
Note: Values are shown as N(%) unless otherwise stated.
For almost two-thirds of infants who required transfer, a call was made to the transfer team within two 
hours of birth (60%, n=27 of 45; missing data for 11 infants). A call was made between two and three 
hours for one-quarter of infants requiring transport (24.5%; n=11). Half of infants requiring transfer 
(44.6%; n=25 of 54; missing data for two infants) departed the referral hospital within six hours of birth 
(Table 30).




Health Service  
Executive 
N=7
Call for transport within 2 hours 27(56.3%)* 0(0)**
Departed referring unit within 6 hours     19(39.6)* 6(100)*
Admitted to tertiary unit within 6 hours    2(4.1) 5(71.4)
Note: Values are shown as N(%) unless otherwise stated.  
*Missing data for one infant. **Data missing for six infants. 
As illustrated in Figure 6, two-thirds of the infants transferred had a core temperature between 33°C and 
34°C on departure from the referring hospital (70.5%, n=31 of 44; data missing for twelve infants) with 
one-quarter of infants (25.0%; n=11 of 44; data missing for twelve infants) having a core temperature 
ranging from 34.1°C to 36.8°C. 
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Figure 6: Temperature (°C) of infant by age (mins) on departure from referring hospital 
Over two-thirds of the 56 infants transferred for neonatal therapeutic hypothermia treatment required 
respiratory support (71.4%; n=40) and sedation (67.9%; n=38) en-route to a tertiary unit (Table 31). 





Respiratory support 38(77.6) 2(28.6)
Ventilation* 31 of 36(86.1) 2of 2 (100)
CPAP* 3 of 36(8.3) -
Nasal prong O2* 2 of 36(5.6) -
Sedation 36(73.5) 2(28.6)
IV access 46(93.9) 7(100)
Peripheral 42 of 46(91.3) 7(100)
UVC 36 of 46(78.3) 3(42.9)
UAC 22 of 46(47.8) 2(28.6)
Note: Values are shown as N(%) unless otherwise stated. *Data missing for two infants
Eighty-seven percent of the infants requiring transfer to a tertiary unit for therapeutic hypothermia 
treatment were admitted more than six hours after birth (87.0%; 47 of 54; missing data for 2 infants). 
One third (32.1%; n=18 of 56) of the infants requiring transfer to a tertiary unit for neonatal therapeutic 
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As illustrated in Figure 7, three-quarters of infants had a core temperature between 33°C and 34°C 
(77.4%, n=41 of 53; data missing for three infants) on admission to a tertiary unit. While 15.1% had a core 
temperature ranging from 34.1°C to 36.6°C.
Figure 7: Temperature (°C) of infant by age (mins) on admission to a tertiary unit from a referring hospital
Treatment Days 1-3
In line with practice guidelines, therapeutic hypothermia should be started within 6 hours of birth and 
should be continued for 72 hours. The optimum core temperature of 33°C to 34°C is targeted over this 
72 hour period. The time that the optimum core temperature was reached was recorded for 126 of the 
140 infants (90.0%). Of these 78.9% of infants were reported to have achieved optimum core temperature 
within 6 hours of birth. 
As illustrated in Figure 8, three-quarters of infants (74.5%; n=102 of 137: data missing for three infants) 
began therapeutic hypothermia at the optimum core temperature of 33°C to 34°C. Seven infants (5.1%, n=7 
of 137) had a temperature which was below optimum as therapeutic hypothermia began, these infants had 
temperatures ranging from 32.4°C to 32.9°C. 
Twenty eight infants (20.4%; n=28 of 137) began therapeutic hypothermia with core temperature ranging 
from 34.1 °C to 36.8°C. Within two hours of therapeutic hypothermia those who were above optimum 
temperature had reduced from 20.4% to 3.0%. No infants were above optimum temperature after 54 hours 
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Figure 8: Percentage of infants at optimum temperature (33-34°C) over 72 hours of therapeutic 
hypothermia 
As outlined in Table 32, almost all infants who were admitted for neonatal therapeutic hypothermia 
received sedation on Day 1 (98.6%; n=138 of 140), Day 2 (96.4%; n=135 of 140) and Day 3 (90.0%; 
n=126 of 140) of treatment. The vast majority of infants were administered antibiotics on Day 1 and 
Day 2 of treatment with almost half receiving antibiotics on Day 3 (47.1%; n=66).







Sedation 138(98.6) 135(96.4) 126(90.0)
Antibiotics 134(95.7) 122(87.1) 66(47.1)
Anticonvulsants 52(37.1) 38(27.1) 25(17.9)
Inotropes 34(24.3) 25(17.9) 18(12.9)
Blood products 27(19.3) 12(8.6) 4(2.9)
Volume replacement 18(12.9) 12(8.6) 5(3.6)
Other 36(25.7) 29(20.7) 23(16.4)
Note: Values are shown as N(%) unless otherwise stated. Categories are not mutually exclusive.
As outlined in Tables 33 and 34 a number of diagnostic investigations were undertaken during the 72 

























Hours since cooling began
Greater than 34°C 33.5-34°C 33.0-33.4°C Less than 33°C
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Haematology 23(16.4) 5(3.5) 3(2.1)
Coagulation 12(8.6) 6(4.3) 0(0)
Biochemistry 22(15.7) 14(10.0) 9(6.4)
LP 6(4.3) 3(2.1) 1(0.7)
Metabolic Screen 8(5.7) 2(1.4) 1(0.7)
Note: Values are shown as N(%) unless otherwise stated. Categories are not mutually exclusive.  
*Data for laboratory tests which may have been undertaken during assessment for therapeutic hypothermia were not 
recorded and therefore are not presented here. 
In relation to neuro imaging, 71.4% (n=100) of infants had a cranial ultrasound in the first three days of life. 
Eleven of these 100 infants had more than one cranial ultrasound undertaken. During the three day period, 
2.1% of infants (n=3) had magnetic resonance imaging (MRI) of the brain undertaken in Day 1 (Table 34).







Cranial ultrasound 56(40.0) 32(22.9) 24(17.1)
MRI of the brain 3(2.1) 0(0) 0(0)
Cardiac echo 21(15.0) 13(9.3) 1(0.7)
Note: Values are shown as N(%) unless otherwise stated. Categories are not mutually exclusive.
SARNAT Scoring
Infants were assigned a SARNAT15 score based on clinical behaviour on Day 1, Day 2 and Day 3 of treatment 
(Table 35). A diagnosis of encephalopathy, consisting of an altered state of consciousness (lethargy, stupor 
or coma) was only assigned to half of infants who had the SARNAT completed over the 72 hour period of 
therapeutic hypothermia. As outlined in Table 36, half of infants were graded as moderately encephalopathic 
on Day 1 (55.4%; 41 of 74), Day 2 (44.9%; 22 of 49) and Day 3 (47.7%; 21 of 44) of treatment. 
Electrical seizures were identified in 50 of the 140 infants (35.7%) on Day 1, 32 of the infants (22.9%) on Day 
2 and 14 of all the infants (10.0%) on Day 3. 
Table 35: SARNAT Scoring on Treatment Day 1, 2 & 3
Day 1 Day 2 Day 3
Level of consciousness
Hyper alert 22(15.7) 11(7.9) 5(3.6)
Lethargic or obtunded 53(37.9) 37(26.4) 33(23.6)
Stupor or Coma 13(9.3) 7(5.0) 7(5.0)
Normal 30(21.4) 26(18.6) 39(27.9)
Undocumented 22(15.7) 59(42.1) 56(40.0)
Activity
Normal 59(42.1) 43(30.7) 46(32.9)
Decreased 49(35.0) 36(25.7) 30(21.4)
Absent 14(10.0) 8(5.7) 8(5.7)
Undocumented 18(12.9) 53(37.9) 56(40.0)
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Neuromuscular Control
Muscle tone Normal 35(25.0) 37(26.4) 41(29.3)
Mild hypotonia 63(45.0) 24(17.1) 18(12.9)
Flaccid 22(15.7) 13(9.3) 9(6.4)
Undocumented 20(14.3) 66(48.2) 72(51.4)
Posture Mild distal flexion 13(9.3) 10(7.1) 12(8.6)
Strong distal flexion 10(7.1) 5(3.6) 7(5.0)
Intermittent decerebration 4(2.9) 3(2.1) 1(0.7)
Normal 9(6.4) 3(2.1) 4(2.9)
Undocumented 104(74.3) 119(85.0) 116(82.8)
Stretch reflexes Overactive 7(5.0) 2(1.4) 2(1.4)
Decreased or absent 12(8.6) 6(4.3) 5(3.6)
Normal 24(17.1) 20(14.3) 20(14.3)
Undocumented 97(69.3) 112(80.7) 113(80.7)
Complex Reflexes
Suck Weak 49(35.0) 37(26.4) 25(17.9)
Weak or absent 10(7.1) 7(5.0) 4(2.9)
Absent 30(21.4) 13(9.3) 14(10.0)
Normal 24(17.1) 18(12.9) 25(17.9)
Undocumented 27(19.3) 65(46.4) 72(51.4)
Moro Strong; low threshold 5(3.6) 4(2.9) 3(2.1)
Weak; incomplete high threshold 19(13.6) 4(2.9) 5(3.6)
Absent 12(8.6) 2(1.4) 2(1.4)
Normal 15(10.7) 11(7.9) 10(7.1)
Undocumented 89(63.6) 119(85.0) 120(85.7)
Tonic Neck Slight 5(3.6) 0(0) 1(0.7)
Strong 1(0.7) 0(0) 0(0)
Absent 5(3.6) 1(0.7) 0(0)
Normal 1(0.7) 1(0.7) 2(1.4)
Undocumented 128(91.4) 138(98.6) 137(97.9)
Autonomic Function
Pupils Mydriasis 3(2.1) 2(1.4) 0(0)
Miosis 19(13.6) 5(3.6) 4(2.9)
Variable; often unequal,  
poor light reflex, fixed, dilated 
20(14.3) 13(9.3) 7(5.0)
Normal 44(31.4) 28(20.0) 30(21.4)
Undocumented 54(38.6) 92(65.7) 99(70.7)
Heart rate Tachycardia 2(1.4) 1(0.7) 0(0)
Bradycardia 105(75.0) 110(78.6) 108(77.1)
Variable 23(16.4) 12(8.6) 15(10.7)
Normal 7(5.0) 6(4.3) 4(2.9)
Undocumented 3(2.1) 11(7.9) 13(9.3)
Seizures None 96(68.6) 99(70.7) 113(80.7)




Normal 0(0) 0(0) 0(0)
Undocumented 3(2.1) 9(6.4) 10(7.1)
Note: Values are shown as N(%) unless otherwise stated.
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Mild HIE 7(9.5) 5(10.2) 6(13.6)
Mild-Moderate HIE 8(10.8) 7(14.3) 3(6.8)
Moderate HIE 41(55.4) 22(44.9) 21(47.7)
Moderate to Severe HIE  1(1.4) 3(6.1) 1(2.3)
Severe HIE 17(22.9) 12(24.5) 13(29.5)
Note: Values are shown as N(%) unless otherwise stated.
Rewarming
Of the 140 infants who underwent therapeutic hypothermia treatment, 13 infants (9.3%) did not complete 
72 hours of therapeutic hypothermia. As outlined in Table 37, three-quarters of these infants had care 
redirect (76.9%; n=10 of 13). 
Table 37: Indication to cease rewarming of infants who underwent therapeutic hypothermia in 2016 or 




Redirection of care 10(76.9)
PPHN 2(15.4)
Sepsis 1(7.7)
Note: Values are shown as N(%) unless otherwise stated.
Excluding the 13 infants whose treatment was ceased, data on rewarming was available for 125 of the 
127 infants (98.4%). As outlined in Table 38, most infants were rewarmed within 12 hours (78.4%; n=98 of 
125). During the rewarming period eight of the 125 infants (6.4%) had seizures. Infants were rewarmed 
over periods between 12 and 72 hours. 





13 – 15 hours 4(3.2)
16 - 18 21(16.8)
Greater than 19 hours 2(1.6)
Note: Values are shown as N(%) unless otherwise stated.
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Feeding
Data on the introduction of feeding was recorded for 126 of the 140 infants who underwent therapeutic 
hypothermia treatment (90.0%). Nine of the 126 mothers’ breastfed (7.1%), three-quarters of infants were 
fed with expressed breastmilk (65.1%; n=82) and over one quarter were fed with formulae (28.6%; n=36). 
As outlined in Table 39, the majority of infants had feed introduced on Day 4 (30.2%; n=38) or Day 5 
(42.1%; n=53). The majority of infants reached full oral requirement (96.8%; n=122 of 126). 










Note: Values are shown as N(%) unless otherwise stated.
Of these 126, over half of infants were initially fed with a nasogastric tube (57.9%; n=73). Of these, one 
quarter of infants were fed with a nasogastric tube for less than 24 hours (24.2%: n=16 of 66; missing data 
for 7 infants). As indicated in Table 40, 11 infants were discharged home with a nasogastric tube (16.7%).
Table 40: Duration of feeding with a nasogastric tube for infants who underwent therapeutic 




Less than 24 hours 16(24.2)
24-47 hours 13(19.7)
48-71 hours 12(18.2)
Greater than 72 hours 14(21.2)
Discharged home with a nasogastric tube 11(16.7)
Note: Values are shown as N(%) unless otherwise stated.
Specific placental conditions 
Of the 136 infants who were born in a maternity unit/hospital, the placenta was retained for 104 (76.5%) 
and histological analysis was performed on all 104 placentas (100%). Of these, 72 (69.2%, n=72 of 104) 
placental examinations were complete, with 59.5% (n=50 of 84) of infants born in tertiary hospital 
having their report completed compared to 39.3% (n=22 of 34) of infants who were not born in a tertiary 
hospital. All 72 completed reports were made available to the NPEC for inclusion in this report. 
Specific placental pathology was present in 60 (83.3%, n=60 of 72) of these infants, with more than 
one placental condition was present for some cases. As outlined in Table 41, the presence of a specific 
condition in these infants was higher than the 66% of placental conditions which were present in 
stillbirths occurring in 2016.16
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Abnormal placental findings have been classified in line with recommendations from the publication 
from the international consensus meeting of pathology.17 These are presented under the following broad 
categories: maternal vascular malperfusion, fetal vascular malperfusion, cord pathology, cord pathology 
with distal disease, chorioamnionitis, villitis and other. 
Chorioamnionitis was present in a quarter of cases (27.8%, n=20). Five of these 20 cases were reported 
as having severe chorioamnionitis present (25%; n=5 of 20). Conditions within the categories of maternal 
vascular malperfusion (26.4%, n=19) and fetal vascular malperfusion (22.2%, n=16) were most commonly 
reported. The prevalence of these major categories, including cord pathology, were similar to those 
reported for stillbirths occurring in 2016 (see Table 41).
Table 41: Placental histology findings for infants who underwent therapeutic hypothermia in 2016 or 







Maternal vascular malperfusion 19(26.4) 73(30.2)
Fetal vascular malperfusion 16(22.2) 64(26.4)
Cord pathology 14(19.4) 44(18.2)
Cord pathology with distal disease N/A 6(2.5)
Chorioamnionitis 20(27.8) 20(8.3)
Villitis 3(4.2) 2(0.8)
Other placental condition 28(38.9) 28(11.6)
Any placental condition 60(83.3) 160(66.1)
Note: Values are shown as N(%) unless otherwise stated. Categories are not mutually exclusive.
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Discharge diagnosis and neonatal death
Of the 140 infants who underwent therapeutic hypothermia treatment, 96 infants (68.6%) had 
magnetic resonance imaging (MRI) of the brain undertaken. The MRI reports were assessed by 
adopting the Barkovich HIE scoring system18. Two-thirds of infants (64.8%; n=61) had a normal MRI 
and one third of infants (35.0; n=34) were reported to have had an abnormal MRI. Of the 34 infants 
were an abnormal MRI, one infant was reported to have had a large focal infarct. Of the 96 MRI 
reports, two reports (2.1%) were unclear and no result was assigned to these two cases. The full set of 
Barkovich HIE scores are outlined in Appendix A. 
A discharge diagnosis was recorded for 128 of the 140 infants. In 7 of the cases no reference was 
made to HIE on discharge (Table 42). When HIE was referenced at discharge, there was no grade of 
encephalopathy assigned to the infant in almost half of cases (43.8%; n=56). 








Moderate to Severe HIE  1(0.8)
Severe HIE 11(8.6)
HIE not documented 7(5.5)
Note: Values are shown as N(%) unless otherwise stated.
The survival rate for the infants who underwent therapeutic hypothermia in 2016 or 2017 was 88%, 
as 17 of the 140 infants died. Almost one third of deaths occurred within 7 completed days of birth 
and were classified as early neonatal deaths (29.4%; n=5). As outlined in Table 43, a third of deaths 
occurred after the 7th day and within 28 completed days of birth and were classified as late neonatal 
deaths (29.4%; n=5 of 17). Twelve infants had an autopsy performed (75.0%; n=12 of 16 infants; 
missing data for one infant). It is important to note that data on the findings of these reports and 
infants cause of death were not collected for this report.





Early neonatal death 5(29.4)
Late neonatal death 6(35.3)
Infant death 6(35.3)
Note: Values are shown as N(%) unless otherwise stated.










1 0 1 Abnormal
1 0 1 Abnormal
0 2 2 Abnormal
0 2 2 Abnormal
4 5 4 Abnormal
0 0 0 Normal
0 0 0 Normal
0 0 0 Normal
0 0 0 Normal
0 0 0 Normal
0 0 0 Normal
0 0 0 Normal
0 0 0 Normal
4 4 3 Abnormal
0 0 0 Normal
0 2 2 Abnormal
0 0 0 Normal
0 0 0 Normal
1 3 3 Abnormal
1 4 3 Abnormal
0 0 0 Normal
0 2 2 Abnormal
0 0 0 Normal
2 2 3 Abnormal
0 0 0 Normal
0 0 0 Normal
0 2 2 Abnormal
0 0 0 Normal
0 0 0 Normal
0 0 0 Normal
0 0 0 Normal
0 0 0 Normal
0 0 0 Normal
0 0 0 Normal
0 0 0 Normal
0 0 0 Normal
0 0 0 Normal
0 0 0 Normal
0 0 0 Normal
0 0 0 Normal
0 0 0 Normal
0 1 2 Abnormal
1 2 3 Abnormal
0 0 0 Normal
0 2 2 Abnormal
0 0 0 Normal
0 0 0 Normal
Appendix A 
Barkovich HIE Scores 
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0 0 0 Normal
0 0 0 Normal
1 0 1 Abnormal
0 0 0 Normal
2 0 1 Abnormal
0 0 0 Normal
0 Unclear 2 Unclear 2 Unclear
0 0 0 Normal
0 0 0 Normal
0 0 0 Normal
0 0 0 Normal
0 0 0 Normal
0 2 2 Abnormal
2 5 3 Abnormal
0 0 0 Normal
0 2 2 Abnormal
0 4 2 Abnormal
1 2 2 Abnormal
1 5 4 Abnormal
0 3 2 Abnormal
1 4 4 Abnormal
Unclear 0 Unclear 0 Unclear 0 Unclear
0 0 0 Normal
0 0 0 Normal
0 0 0 Normal
0 0 0 Normal
0 0 0 Normal
4 4 3 Abnormal
4 0 3 Abnormal
4 4 4 Abnormal
0 0 0 Normal
0 0 0 Normal
0 0 0 Normal
0 0 0 Normal
0 0 0 Normal
0 0 0 Normal
0 4 2 Abnormal
0 0 0 Normal
0 0 0 Normal
0 0 0 Normal
4 2 3 Abnormal
0 0 0 Normal
0 4 2 Abnormal
0 1 3 Abnormal
4 5 4 Abnormal
0 0 0 Normal
0 0 0 Normal
0 0 0 Normal
4 0 1 Abnormal
0 0 0 Normal
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Appendix B  
Neonatal Therapeutic Hypothermia Working Group Members
Ms Ann Bowden  
Co-ordinator, National Neonatal Transport 
Programme, Rotunda Hospital
Ms Lucille Bradfield  
Clinical Nurse Manager, Cork University 
Maternity Hospital
Dr Paul Corcoran  
Senior Lecturer in Perinatal Epidemiology, 
National Perinatal Epidemiology Centre, 
National Perinatal Epidemiology Centre 
contributor
Ms Mandy Daly  
Representative from a Patient Advocacy 
Group (Director of Advocacy & Policy Making, 
Irish Neonatal Health Alliance (INHA))
Dr Linda Drummond  
Manager, National Perinatal Epidemiology 
Centre, National Perinatal Epidemiology 
Centre contributor
Dr Peter Filan  
Consultant Neonatologist, Cork University 
Maternity Hospital
Prof Adrienne Foran  
Consultant Neonatologist, Rotunda Hospital
Prof Richard Greene  
Consultant Obstetrician & Gynaecologist, 
Cork University Maternity Hospital, Director of 
the National Perinatal Epidemiology Centre
Ms Siobhan Horkan  
Programme Manager, National Clinical 
Programmes, Royal College of Physicians
Ms Julie Mc Ginley  
Therapeutic Hypothermia Co-Ordinator, 
National Programme Paediatrics & 
Neonatology, Royal College of Physicians
Dr Peter McKenna  
Consultant Obstetrician & Gynaecologist, 
National Clinical Director, National Women 
and Infants Health Programme
Dr Sarah Meaney  
Researcher, National Perinatal Epidemiology 
Centre. National Perinatal Epidemiology 
Centre contributor
Prof Eleanor Molloy  
Chair of Paediatrics, Trinity College Dublin.
Dr Eoghan Mooney  
Consultant Pathologist, National Maternity 
Hospital 
Prof John Murphy  
Lead, Consultant Neonatologist, National 
Maternity Hospital, Director, National Clinical 
Programme in Paediatrics & Neonatology
Dr Veronica O Donohue  
Consultant Radiologist, National Maternity 
Hospital
Mr Cathal O Keeffe  
Head of Clinical Risk, State Claims Agency
Dr Marie Slevin  
Clinical Psychologist, National Maternity 
Hospital
Dr Deirdre Sweetman  
Consultant Neonatologist, National Maternity 
Hospital
Dr Mathew Thomas  
Consultant Paediatrician, Letterkenny 
University Hospital 
Prof Martin White  
Consultant Neonatologist, Coombe Women 
& Infants University Hospital and Our Lady’s 
Children’s Hospital Crumlin. 
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Appendix C
Link Representatives from each of the Hospital Sites
Cavan General Hospital; Dr Alan Finan
Coombe Women & Infants University Hospital; Dr Martin White/ Ms Anne O’Sullivan
Cork University Maternity Hospital; Dr Peter Filan/ MsLucille Bradfield
Kerry General Hospital; Dr Pervaiz/ Ms Maudie Creagh
Letterkenny General Hospital; Dr Mathew Kathleen Greenaough
Mayo General Hospital; Ms Andrea McGrail
Midland Regional Hospital, Mullingar; Ms Geraldine Kavanagh
Midland Regional Hospital, Portlaoise; Dr Gallagher/ Ms Anne Blanche
National Maternity Hospital; Prof John Murphy/ Ms Julie McGinley
Our Lady of Lourdes Hospital, Drogheda; Ms Claire Shannon
Portiuncula Hospital; Ms Pricillia Neilan
Rotunda Hospital; Prof Adrienne Foran/ Ms Siobhan Mulvany
Sligo University Hospital; Dr Nath Tummuluru/ Ms Madeleine Munnelly
South Tipperary General Hospital; Dr Isam/ Maura Grogan
St. Luke’s General Hospital, Kilkenny; Ms Breda O’Dwyer
University Hospital Galway; Ms Jean James
University Hospital Limerick; Ms Margo Dunworth
University Hospital Waterford; Ms Audrey Comerford/ Ms Paula Curtain
Wexford General Hospital; Ms Helen McLoughlin
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